Cargando…

Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma

BACKGROUND: Selenium metabolism has been implicated in human health. This study aimed to identify a selenium metabolism regulator-based prognostic signature for hepatocellular carcinoma (HCC) and validate the role of INMT in HCC. METHODS: Transcriptome sequencing data and clinical information relate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Huishan, Long, Junyu, Zuo, Bangyou, Li, Yiran, Song, Yu, Yu, Minghang, Xun, Ziyu, Wang, Yanyu, Wang, Xi, Sang, Xinting, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197375/ https://www.ncbi.nlm.nih.gov/pubmed/37202783 http://dx.doi.org/10.1186/s12885-023-10944-w

Ejemplares similares

Differentially expressed liver exosome-related genes as candidate prognostic biomarkers for hepatocellular carcinoma
por: Zuo, Bangyou, et al.
Publicado: (2022)

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma
por: Xun, Ziyu, et al.
Publicado: (2023)

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
por: Mao, Jinzhu, et al.
Publicado: (2021)

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma
por: Liao, Wanying, et al.
Publicado: (2022)

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma
por: Xie, Fucun, et al.
Publicado: (2022)

Construction and validation of a prognostic signature using CNV-driven genes for hepatocellular carcinoma
por: Bian, Jin, et al.
Publicado: (2021)

Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
por: Yang, Xu, et al.
Publicado: (2023)

The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2019)

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
por: Zhu, Chengpei, et al.
Publicado: (2023)

Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Association of chronic liver disease with the prognosis of COVID-19 patients
por: Long, Junyu, et al.
Publicado: (2022)

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study
por: Wang, Dongxu, et al.
Publicado: (2021)

N6-methyladenosine associated prognostic model in hepatocellular carcinoma
por: Huang, Hanchun, et al.
Publicado: (2020)

Development and Validation of a Metabolic-related Prognostic Model for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Development and validation of a CTNNB1‐associated metabolic prognostic model for hepatocellular carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma
por: Wang, Yunchao, et al.
Publicado: (2022)

Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer
por: Zhu, Chengpei, et al.
Publicado: (2023)

Identification of hub genes involved in the development of hepatocellular carcinoma by transcriptome sequencing
por: Zheng, Yongchang, et al.
Publicado: (2017)

Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma
por: Yang, Huibin, et al.
Publicado: (2021)

Comprehensive analysis of a ceRNA network reveals potential prognostic cytoplasmic lncRNAs involved in HCC progression
por: Bai, Yi, et al.
Publicado: (2019)

Metabolic Tumor Volume Measured by (18)F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents
por: Wang, Xuezhu, et al.
Publicado: (2023)

Mechanisms of Hepatocellular Injury in Hepatitis A
por: Wang, Minghang, et al.
Publicado: (2021)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Development and Validation of a Prognostic Nomogram for Gastric Cancer Based on DNA Methylation-Driven Differentially Expressed Genes
por: Bai, Yi, et al.
Publicado: (2020)

Identification of TMB, CD8 T‐cell abundance, and homologous repair pathway mutation frequency as predictors of the benefit–toxicity ratio of anti‐PD‐1/PD‐L1 therapy
por: Long, Junyu, et al.
Publicado: (2021)

Prognostic value and underlying mechanism of KIAA0101 in hepatocellular carcinoma: database mining and co-expression analysis
por: Xu, Weiyu, et al.
Publicado: (2020)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

Selenium and thyroid diseases
por: Wang, Fei, et al.
Publicado: (2023)

A four‐gene‐based prognostic model predicts overall survival in patients with hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2018)

Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy
por: Long, Junyu, et al.
Publicado: (2021)

Development and validation of prognostic nomograms for large hepatocellular carcinoma after HAIC
por: Yao, Wang, et al.
Publicado: (2023)

Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma
por: Xu, Weiyu, et al.
Publicado: (2020)

Identification and validation of a glycolysis-associated multiomics prognostic model for hepatocellular carcinoma
por: Deng, Tuo, et al.
Publicado: (2021)

Effect of ultrasonic-induced selenium crystallization behavior during selenium reduction
por: Yang, Zheng, et al.
Publicado: (2023)

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape
por: Long, Junyu, et al.
Publicado: (2022)

Development and Validation of a Novel Immune-Gene Pairs Prognostic Model Associated with CTNNB1 Alteration in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2020)

Development and validation of a prognostic and immunotherapeutically relevant model in hepatocellular carcinoma
por: Wang, Yu, et al.
Publicado: (2020)

ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
por: Zhang, Chaohua, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7qd5hs1sur4gfg2m24bku8u1he